Axonics, Inc.

AXNX · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Valuation
PEG Ratio5.541.57-1.170.71
FCF Yield-0.18%0.03%-2.05%-4.70%
EV / EBITDA382.91-57.03-35.66-31.90
Quality
ROIC-2.68%-6.80%-12.99%-16.79%
Gross Margin74.94%72.22%64.18%60.15%
Cash Conversion Ratio0.33-0.050.591.52
Growth
Revenue 3-Year CAGR26.66%34.88%135.41%440.34%
Free Cash Flow Growth-675.00%101.95%42.82%-2.23%
Safety
Net Debt / EBITDA-9.934.873.414.09
Interest Coverage0.00-17.41-9.08-28.69
Efficiency
Inventory Turnover1.151.360.990.70
Cash Conversion Cycle301.44283.92382.65490.13